Skip to main content
. 2021 Sep 7;8:709404. doi: 10.3389/fmed.2021.709404

Figure 3.

Figure 3

Reduction of CCL19 and CCL21 expression under glucocorticoid therapy. Temporal artery sections of patients were stained with (A) anti-CCL19 mAb and (B) anti-CCL21 mAB, respectively, and numbers of positive cells were determined in three sections. For each patient and control patient, positive cells were counted in three different temporal artery sections.